LOGIN 
 

JOIN
 

RENEW
 

CME/MOC

 

SEARCH

Pulmonary Hypertension

Home ▶ Patients ▶ Lung Disease Week at the ATS ▶ 2020 ▶ Pulmonary Hypertension ▶ Information for Experts


Information for Experts

ph

 

ClinicianATS Educational Products on PH

 

CROSSING THE BORDER: MILDLY INCREASED PULMONARY ARTERY PRESSURE AND THE NEW DEFINITION OF PULMONARY HYPERTENSION

FORGOTTEN AND CONTROVERSIAL TOPICS IN PULMONARY HYPERTENSION

FROM CANCER BIOLOGY TO NEW THERAPEUTICS: TARGETING CELL PROLIFERATION SIGNALING HUBS IN PULMONARY HYPERTENSION AND FIBROSIS

EMERGING CONCEPTS IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

 

 

ClinicianATS Journals Articles on Pulmonary Hypertension

 

American Journal of Respiratory Cell and Molecular Biology

DNGR1-Cre–mediated Deletion of Tnfaip3/A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice
2020
Link to Abstract

Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia–induced Pulmonary Hypertension
2020
Link to Abstract

Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine
2020
Link to Abstract

Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension
2020
Link to Abstract

Optimal Oxygen Targets in Term Lambs with Meconium Aspiration Syndrome and Pulmonary Hypertension
2020
Link to Abstract

Heart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension
2020
Link to Abstract

4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension
2020
Link to Abstract

Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α
2020
Link to Abstract

Basement Membrane Remodeling Controls Endothelial Function in Idiopathic Pulmonary Arterial Hypertension
2020
Link to Abstract

AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension
2019
Link to Abstract

Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension
2020
Link to Abstract

Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats
2019
Link to Abstract

Rats with a Human Mutation of NFU1 Develop Pulmonary Hypertension
2019
Link to Abstract

Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension
2019
Link to Abstract

Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition
2019
Link to Abstract

Slide-Seq for Spatially Mapping Gene Expression. Metabolic Syndrome Exacerbates Group 2 Pulmonary Hypertension, and NAD Metabolism Is Influenced by Tissue Origin
2019
Link to Abstract

Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension
2019
Link to Abstract

Endothelial–Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension
2019
Link to Abstract

Airway Epithelial Genomic Signatures in Steroid-Resistant COPD; Role for SMAD3 in Vascular Remodeling in Pulmonary Hypertension; Regulation of Lung Endothelial Cell Function by VEGFR3
2019
Link to Abstract

Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome
2019
Link to Abstract

AMP Kinase Activation Attenuates Cardiac Remodeling in Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction; Lung Epithelial Progenitor Cells in Alveolar Regeneration; and Drug Discovery and Novel Therapies for Lung Cancer
2019
Link to Abstract

Hypoxia-induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome
2019
Link to Abstract

 

Annals of ATS

Association between Pre-operative Dynamic Measures of Vascular Load and Post-operative Hemodynamics in Patients with Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Thromboendarterectomy
2020
Link to Abstract

Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study
2020
Link to Abstract

Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)
2020
Link to Abstract

Clinical Differences and Outcomes between Methamphetamine-Associated and Idiopathic Pulmonary Arterial Hypertension in the PHAR
2020
Link to Abstract

Outcome Measures Used in Studies of Rehabilitation in Pulmonary Hypertension: A Systematic Review
2020
Link to Abstract

Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk Stratify Patients with Pulmonary Arterial Hypertension
2020
Link to Abstract

Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension
2020
Link to Abstract

Swan-Ganz and Pericardial Pressure–guided Pericardiocentesis in PulmonaryArterial Hypertension–associated Cardiac Tamponade
2019
Link to Abstract

Unbiased Phenome-Wide Association Studies of Red Cell Distribution Width Identifies Key Associations with Pulmonary Hypertension
2019
Link to Abstract

 

American Journal of Respiratory and Critical Care Medicine

TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2
2020
Link to Abstract

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce De Résistance?
2020
Link to Abstract

Reply to: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce De Résistance?
2020
Link to Abstract

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension
2020
Link to Abstract

Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting Against Colitis
2020
Link to Abstract

Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
2020
Link to Abstract

Single-cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning
2020
Link to Abstract

Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials
2020
Link to Abstract

Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1
2020
Link to Abstract

Pulmonary Vascular Pruning on Computed Tomography and Risk of Death in the Framingham Heart Study
2020
Link to Abstract

Pulmonary Hypertension: Advances in Risk Assessment and Emerging Procedures
2020
Link to Abstract

Pulmonary Hypertension Complicating Pulmonary Artery Involvement in Pseudoxanthoma Elasticum
2020
Link to Abstract

Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension
2020
Link to Abstract

PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
2020
Link to Abstract

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
2020
Link to Abstract

A New “TYK” Tok Era for the Study of Long Non-Coding RNAs in Pulmonary Hypertension
2020
Link to Abstract

BMPR2 Mutation Carriers: Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension Without Symptoms: Cautionary Tales?
2020
Link to Abstract

Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-Mediated Regulation of PDGFRβ
2020
Link to Abstract

 

 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document. There is no charge for this service.